For people with heart disease and high levels of a fatty protein called lipoprotein(a), a new drug called olpasiran mostly caused only mild reactions at the injection site, like redness or soreness,...
66
0
Evidence from Studies
Supporting (1)
66
Community contributions welcome
66
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
Randomized Controlled Trial
Human
2022 Nov 17Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.